Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis

NCT00833079 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
500
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sun Pharmaceutical Industries, Inc.